• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型磷酸吡哆醛-5'-磷酸衍生物PPNDS能有效拮抗P2X(1)受体的激活。

The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors.

作者信息

Lambrecht G, Rettinger J, Bäumert H G, Czeche S, Damer S, Ganso M, Hildebrandt C, Niebel B, Spatz-Kümbel G, Schmalzing G, Mutschler E

机构信息

Department of Pharmacology, Biocentre Niederursel, University of Frankfurt, Geb. N260, Marie-Curie-Str. 9, D-60439, Frankfurt, Germany.

出版信息

Eur J Pharmacol. 2000 Jan 17;387(3):R19-21. doi: 10.1016/s0014-2999(99)00834-1.

DOI:10.1016/s0014-2999(99)00834-1
PMID:10650184
Abstract

Pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonat e) (PPNDS) potently antagonized P2X(1) receptor-mediated responses in rat vas deferens (pK(B)=7.43) and Xenopus laevis oocytes (pIC(50)=7. 84). It showed lower (up to 20,000-fold) inhibitory potency on ecto-nucleotidase in Xenopus oocytes and on P2Y(1) receptors in guinea-pig ileum (pA(2)=6.13). PPNDS did not interact with alpha(1A)-adrenoceptors, adenosine A(1) and A(2B), histamine H(1) and muscarinic M(3) receptors. Thus, PPNDS is a novel, specific P2 receptor antagonist and represents the pyridoxal-5'-phosphate derivative with the highest potency at P2X(1) receptors.

摘要

磷酸吡哆醛-5'-磷酸-6-(2'-萘基偶氮-6'-硝基-4',8'-二磺酸盐)(PPNDS)能有效拮抗大鼠输精管中P2X(1)受体介导的反应(pK(B)=7.43)以及非洲爪蟾卵母细胞中的反应(pIC(50)=7.84)。它对非洲爪蟾卵母细胞中的外切核苷酸酶以及豚鼠回肠中的P2Y(1)受体的抑制效力较低(高达20000倍)(pA(2)=6.13)。PPNDS不与α(1A)-肾上腺素能受体、腺苷A(1)和A(2B)、组胺H(1)和毒蕈碱M(3)受体相互作用。因此,PPNDS是一种新型的特异性P2受体拮抗剂,是在P2X(1)受体上效力最高的磷酸吡哆醛-5'-磷酸衍生物。

相似文献

1
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors.新型磷酸吡哆醛-5'-磷酸衍生物PPNDS能有效拮抗P2X(1)受体的激活。
Eur J Pharmacol. 2000 Jan 17;387(3):R19-21. doi: 10.1016/s0014-2999(99)00834-1.
2
The novel heteromeric bivalent ligand SB9 potently antagonizes P2Y(1) receptor-mediated responses.新型异源二聚体二价配体SB9能有效拮抗P2Y(1)受体介导的反应。
J Auton Nerv Syst. 2000 Jul 3;81(1-3):171-7. doi: 10.1016/s0165-1838(00)00135-1.
3
Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.嘌呤受体拮抗剂苏拉明和吡哆醛-5'-磷酸-6-(2'-萘基偶氮-6'-硝基-4',8'-二磺酸盐)(PPNDS)对α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体的不同作用。
Mol Pharmacol. 2004 Dec;66(6):1738-47. doi: 10.1124/mol.104.003038. Epub 2004 Sep 24.
4
NF279: a novel potent and selective antagonist of P2X receptor-mediated responses.NF279:一种新型的强效且选择性的P2X受体介导反应拮抗剂。
Eur J Pharmacol. 1998 May 29;350(1):R5-6. doi: 10.1016/s0014-2999(98)00316-1.
5
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.NF449:重组大鼠P2X1受体的一种亚纳摩尔效价拮抗剂。
Naunyn Schmiedebergs Arch Pharmacol. 2001 Sep;364(3):285-90. doi: 10.1007/s002100100463.
6
Investigation of the actions of PPADS, a novel P2x-purinoceptor antagonist, in the guinea-pig isolated vas deferens.新型P2x嘌呤受体拮抗剂PPADS对豚鼠离体输精管作用的研究。
Br J Pharmacol. 1994 Mar;111(3):913-7. doi: 10.1111/j.1476-5381.1994.tb14825.x.
7
PPNDS is an agonist, not an antagonist, for the ATP receptor of Paramecium.
J Exp Biol. 2003 Feb;206(Pt 3):627-36. doi: 10.1242/jeb.00105.
8
ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens.三磷酸腺苷(ATP)通过激活大鼠输精管中的抑制性P2Y受体和促进性P2X受体来调节去甲肾上腺素的释放。
J Pharmacol Exp Ther. 2003 Nov;307(2):809-15. doi: 10.1124/jpet.103.054809. Epub 2003 Sep 9.
9
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.磷酸吡哆醛衍生物作为P2X1受体强效和选择性拮抗剂的构效关系
J Med Chem. 2001 Feb 1;44(3):340-9. doi: 10.1021/jm9904203.
10
Functional expression of muscarinic and purinoceptors in the urinary bladder of male and female rats and guinea pigs.毒蕈碱受体和嘌呤受体在雄性和雌性大鼠及豚鼠膀胱中的功能表达。
J Smooth Muscle Res. 2010;46(4):201-15. doi: 10.1540/jsmr.46.201.

引用本文的文献

1
Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists.非 ATP 类似物拮抗剂对 P2X 受体的变构抑制作用的结构见解。
Elife. 2024 Apr 5;12:RP92829. doi: 10.7554/eLife.92829.
2
The P2X1 receptor as a therapeutic target.P2X1 受体作为治疗靶点。
Purinergic Signal. 2022 Dec;18(4):421-433. doi: 10.1007/s11302-022-09880-4. Epub 2022 Jul 11.
3
Predicting New Anti-Norovirus Inhibitor With the Help of Machine Learning Algorithms and Molecular Dynamics Simulation-Based Model.借助机器学习算法和基于分子动力学模拟的模型预测新型抗诺如病毒抑制剂
Front Chem. 2021 Nov 17;9:753427. doi: 10.3389/fchem.2021.753427. eCollection 2021.
4
Discovery and Characterization of Two Classes of Selective Inhibitors of the Suppressor of the TCR Signaling Family of Proteins.TCR信号蛋白家族抑制因子两类选择性抑制剂的发现与特性研究
ACS Infect Dis. 2019 Feb 8;5(2):250-259. doi: 10.1021/acsinfecdis.8b00238. Epub 2018 Dec 14.
5
Actions of a Series of PPADS Analogs at P2X and P2X Receptors.一系列PPADS类似物对P2X和P2X受体的作用。
Drug Dev Res. 2001 Aug;53(4):281-291. doi: 10.1002/ddr.1197. Epub 2001 Oct 18.
6
High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry Inhibitors.用于发现病毒进入抑制剂的高通量HIV细胞融合测定法。
Assay Drug Dev Technol. 2015 Apr;13(3):155-66. doi: 10.1089/adt.2015.639. Epub 2015 Apr 14.
7
Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and β.金属蛋白酶meprin α和β抑制剂的高通量筛选检测方法的开发及初步筛选
Biopolymers. 2014 Sep;102(5):396-406. doi: 10.1002/bip.22527.
8
P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.P2X 选择性嘌呤能拮抗剂是细胞间和无细胞感染过程中 HIV-1 融合的强抑制剂。
J Virol. 2014 Oct;88(19):11504-15. doi: 10.1128/JVI.01158-14. Epub 2014 Jul 16.
9
Role of purinergic P2X receptors in the control of liver homeostasis.嘌呤能P2X受体在肝脏稳态调控中的作用。
Wiley Interdiscip Rev Membr Transp Signal. 2012 May;1(3):341-348. doi: 10.1002/wmts.32. Epub 2012 Jan 11.
10
Development of a comprehensive set of P2 receptor pharmacological research compounds.开发一套全面的 P2 受体药理学研究化合物。
Purinergic Signal. 2012 Feb;8(Suppl 1):101-12. doi: 10.1007/s11302-011-9270-7. Epub 2011 Nov 4.